Publication | Open Access

Nanoparticle–chelator conjugates as inhibitors of amyloid-β aggregation and neurotoxicity: A novel therapeutic approach for Alzheimer disease

NanoparticlesNanomedicineNeurodegenerative DiseasesAlzheimer's DiseaseEngineeringTherapeutic NanomaterialsMedicineNanoparticle–chelator ConjugatesAmyloid-β AggregationNano-drug DeliveryAlzheimer DiseasePharmacologyBiomolecular Engineering